Central Research Laboratory of Darfur Universities, Nyala, Sudan.
Faculty of Veterinary Science, University of Nyala, Nyala, Sudan.
PLoS One. 2024 Jun 11;19(6):e0301554. doi: 10.1371/journal.pone.0301554. eCollection 2024.
In Sudan, resistance to benzimidazoles has been reported recently in cattle and goats from South Darfur. Herein, ivermectin efficacy against gastrointestinal nematodes (GINs) was evaluated in sheep and goats in three study areas in South Darfur. The faecal egg count reduction test (FECRT) was used to evaluate the efficacy of ivermectin in sheep and goats naturally infected with GINs in the region of Bulbul (goats: n = 106), Kass (goats: n = 40) and Nyala (Domaia (sheep: n = 47, goats: n = 77) and the University farm (goats: n = 52)), using different treatment plans, and the efficacy was evaluated 12 days after treatment. Ivermectin efficacy was also evaluated in goats experimentally infected using local Haemonchus contortus isolates from Kass and Nyala. Nematodes surviving ivermectin treatment in goats in Bulbul and Nyala were harvested and larvae used to infect worm-free male sheep (n = 6, ≤6 months old). Infected sheep were dosed subcutaneously with ivermectin every eight days with increasing doses from 0.2 mg/kg to 1.6 mg/kg bodyweight (bw). Reduced ivermectin efficacy was identified in sheep and goats in the four study locations. Using a paired statistic, the efficacy of a therapeutic dose in sheep was 75.6% (90% upper credible limit (UCrL): 77.5%), while twice the recommended dose led to a reduction of 92.6% (90% UCrL: 93.3%). In goats, the FECRs of a therapeutic dose were 72.9-95.3% (90% UCrL range: 73.6-95.7%) in Bulbul, Nyala Domaia, Nyala University farm and Kass. Twice the dose recommended for goats in Bulbul revealed a 90% UCrL of 87.6%. All post-treatment faecal cultures contained only Haemonchus spp. larvae. The experimental infection trials in sheep and goats supported our findings from field trials and calculated upper 90% CrL of below 98.9%. For the first time highly ivermectin resistant H. contortus populations have been identified in sheep and goats in Sudan, and resistance was experimentally confirmed.
在苏丹,最近报道南达尔富尔的牛和山羊对苯并咪唑类药物产生了耐药性。在此,我们评估了伊维菌素在南达尔富尔三个研究地区感染胃肠道线虫(GINs)的绵羊和山羊中的疗效。采用粪便卵计数减少试验(FECRT)评估 Bulbul 地区(山羊:n = 106)、Kass 地区(山羊:n = 40)和 Nyala 地区(Domaia 绵羊:n = 47,山羊:n = 77)和大学农场(山羊:n = 52)中自然感染 GINs 的绵羊和山羊中伊维菌素的疗效,使用不同的治疗方案,并在治疗后 12 天评估疗效。我们还评估了 Kass 和 Nyala 当地感染 Haemonchus contortus 分离株的山羊的伊维菌素实验感染。在 Bulbul 和 Nyala 接受伊维菌素治疗的山羊中存活下来的线虫被收获,幼虫用于感染无蠕虫的雄性绵羊(n = 6,≤6 个月大)。感染的绵羊每隔 8 天皮下注射伊维菌素,剂量从 0.2 mg/kg 增加到 1.6 mg/kg 体重(bw)。在四个研究地点的绵羊和山羊中,伊维菌素的疗效降低。使用配对统计,绵羊治疗剂量的疗效为 75.6%(90%置信上限(UCrL):77.5%),而推荐剂量的两倍导致降低 92.6%(90%UCrL:93.3%)。在山羊中,治疗剂量的 FECR 为 72.9-95.3%(90%UCrL 范围:73.6-95.7%),在 Bulbul、Nyala Domaia、Nyala 大学农场和 Kass。Bulbul 中推荐剂量的两倍,90%UCrL 为 87.6%。所有治疗后粪便培养物仅含有 Haemonchus spp.幼虫。绵羊和山羊的实验感染试验支持我们从现场试验中得出的结果,并计算出 90%CrL 低于 98.9%。这是苏丹首次在绵羊和山羊中发现高度耐伊维菌素的 Haemonchus contortus 种群,并且已通过实验证实了耐药性。